Search bioRxivSearch

SEARCH · Search bioRxiv

Results for “Bioinformatics”

Search indexed bioRxiv preprints in genomics, neuroscience, cell biology and bioinformatics. Read source abstracts and check manuscript versions; preprints are not peer reviewed.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,531 records · Page 85Linked to original sources

Modeling of RNA-seq fragment sequence bias reduces systematic errors in transcript abundance estimation

RNA-seq technology is widely used in biomedical and basic science research. These studies rely on complex computational methods that quantify expression levels for observed transcripts. We find that current computational methods can lead to hundreds of false positive results related to alternative isoform usage. This flaw in the current methodology stems from a lack of modeling sample-specific bias that leads to drops in coverage and is related to sequence features like fragment GC content and GC stretches. By incorporating features that explain this bias into transcript expression models, we greatly increase the specificity of transcript expression estimates, with more than a four-fold reduction in the number of false positives for reported changes in expression. We introduce alpine, a method for estimation of bias-corrected transcript abundance. The method is available as a Bioconductor package that includes data visualization tools useful for bias discovery.

Bioinformatics

Teaser: Individualized benchmarking and optimization of read mapping results for NGS data

Mapping reads to a genome remains challenging, especially for non-model organisms with poorer quality assemblies, or for organisms with higher rates of mutations. While most research has focused on speeding up the mapping process, little attention has been paid to optimize the choice of mapper and parameters for a users dataset. Here we present Teaser, which assists in these choices through rapid automated benchmarking of different mappers and parameter settings for individualized data. Within minutes, Teaser completes a quantitative evaluation of an ensemble of mapping algorithms and parameters. Using Teaser, we demonstrate how Bowtie2 can be optimized for different data.

Bioinformatics

ProtAnnot: an App for Integrated Genome Browser to display how alternative splicing and transcription affect proteins

SummaryOne gene can produce multiple transcript variants encoding proteins with different functions. To facilitate visual analysis of transcript variants, we developed ProtAnnot, which shows protein annotations in the context of genomic sequence. ProtAnnot searches InterPro and displays profile matches (protein annotations) alongside gene models, exposing how alternative promoters, splicing, and 3 end processing add, remove, or remodel functional motifs. To draw attention to these effects, ProtAnnot color-codes exons by frame and displays a cityscape graphic summarizing exonic sequence at each position. These techniques make visual analysis of alternative transcripts faster and more convenient for biologists. Availability and ImplementationProtAnnot is a plug-in App for Integrated Genome Browser, an open source desktop genome browser available from http://www.bioviz.org. Contactaloraine@uncc.edu

Bioinformatics

Privacy-Preserving Microbiome Analysis Using Secure Computation

MotivationDeveloping targeted therapeutics and identifying biomarkers relies on large amounts of patient data. Beyond human DNA, researchers now investigate the DNA of micro-organisms inhabiting the human body. An individuals collection of microbial DNA consistently identifies that person and could be used to link a real-world identity to a sensitive attribute in a research dataset. Unfortunately, the current suite of DNA-specific privacy-preserving analysis tools does not meet the requirements for microbiome sequencing studies.\n\nResultsWe augment an existing categorization of genomic-privacy attacks to incorporate microbiome sequencing and provide an implementation of metagenomic analyses using secure computation. Our implementation allows researchers to perform analysis over combined data without revealing individual patient attributes. We implement three metagenomic analyses and perform an evaluation on real datasets for comparative analysis. We use our implementation to simulate sharing data between four policy-domains and measure the increase in significant discoveries. Additionally, we describe an application of our implementation to form patient pools of data to allow drug companies to query against and compensate patients for the analysis.\n\nAvailabilityThe software is freely available for download at: http://cbcb.umd.edu/[~]hcorrada/projects/secureseq.html

Bioinformatics

A Comparison of Methods: Normalizing High-Throughput RNA Sequencing Data

As RNA-Seq and other high-throughput sequencing grow in use and remain critical for gene expression studies, technical variability in counts data impedes studies of differential expression studies, data across samples and experiments, or reproducing results. Studies like Dillies et al. (2013) compare several between-lane normalization methods involving scaling factors, while Hansen et al. (2012) and Risso et al. (2014) propose methods that correct for sample-specific bias or use sets of control genes to isolate and remove technical variability. This paper evaluates four normalization methods in terms of reducing intra-group, technical variability and facilitating differential expression analysis or other research where the biological, inter-group variability is of interest. To this end, the four methods were evaluated in differential expression analysis between data from Pickrell et al. (2010) and Montgomery et al. (2010) and between simulated data modeled on these two datasets. Though the between-lane scaling factor methods perform worse on real data sets, they are much stronger for simulated data. We cannot reject the recommendation of Dillies et al. to use TMM and DESeq normalization, but further study of power to detect effects of different size under each normalization method is merited.

Bioinformatics

Revisiting inconsistency in large pharmacogenomic studies

BackgroundIn 2012, two large pharmacogenomic studies, the Genomics of Drug Sensitivity in Cancer (GDSC) and Cancer Cell Line Encyclopedia (CCLE), were published, each reported gene expression data and measures of drug response for a large number of drugs and hundreds of cell lines. In 2013, we published a comparative analysis that reported gene expression profiles for the 471 cell lines profiled in both studies and dose response measurements for the 15 drugs characterized in the common cell lines by both studies. While we found good concordance in gene expression profiles, there was substantial inconsistency in the drug responses reported by the GDSC and CCLE projects. Our paper was widely discussed and we received extensive feedback on the comparisons that we performed. This feedback, along with the release of new data, prompted us to revisit our initial analysis. Here we present a new analysis using these expanded data in which we address the most significant suggestions for improvements on our published analysis: that drugs with different response characteristics should have been treated differently, that targeted therapies and broad cytotoxic drugs should have been treated differently in assessing consistency, that consistency of both molecular profiles and drug sensitivity measurements should both be compared across cell lines to accurately assess differences in the studies, that we missed some biomarkers that are consistent between studies, and that the software analysis tools we provided with our analysis should have been easier to run, particularly as the GDSC and CCLE released additional data.\n\nMethodsFor each drug, we used published sensitivity data from the GDSC and CCLE to separately estimate drug dose-response curves. We then used two statistics, the area between drug dose-response curves (ABC) and the Matthews correlation coefficient (MCC), to robustly estimate the consistency of continuous and discrete drug sensitivity measures, respectively. We also used recently released RNA-seq data together with previously published gene expression microarray data to assess inter-platform reproducibility of cell line gene expression profiles.\n\nResultsThis re-analysis supports our previous finding that gene expression data are significantly more consistent than drug sensitivity measurements. The use of new statistics to assess data consistency allowed us to identify two broad effect drugs -- 17-AAG and PD-0332901 -- and three targeted drugs -- PLX4720, nilotinib and crizotinib -- with moderate to good consistency in drug sensitivity data between GDSC and CCLE. Not enough sensitive cell lines were screened in both studies to robustly assess consistency for three other targeted drugs, PHA-665752, erlotinib, and sorafenib. Concurring with our published results, we found evidence of inconsistencies in pharmacological phenotypes for the remaining eight drugs. Further, to discover \"consistency\" between studies required the use of multiple statistics and the selection of specific measures on a case-by-case basis.\n\nConclusionOur results reaffirm our initial findings of an inconsistency in drug sensitivity measures for eight of fifteen drugs screened both in GDSC and CCLE, irrespective of which statistical metric was used to assess correlation. Taken together, our findings suggest that the phenotypic data on drug response in the GDSC and CCLE continue to present challenges for robust biomarker discovery. This re-analysis provides additional support for the argument that experimental standardization and validation of pharmacogenomic response will be necessary to advance the broad use of large pharmacogenomic screens.

Bioinformatics

Evolution of genes neighborhood within reconciled phylogenies: an ensemble approach

ContextThe reconstruction of evolutionary scenarios for whole genomes in terms of genome rearrangements is a fundamental problem in evolutionary and comparative genomics. The DeCo algorithm, recently introduced by Berard et al., computes parsimonious evolutionary scenarios for gene adjacencies, from pairs of reconciled gene trees. However, as for many combinatorial optimization algorithms, there can exist many co-optimal, or slightly sub-optimal, evolutionary scenarios that deserve to be considered.\n\nContributionWe extend the DeCo algorithm to sample evolutionary scenarios from the whole solution space under the Boltzmann distribution, and also to compute Boltzmann probabilities for specific ancestral adjacencies.\n\nResultsWe apply our algorithms to a dataset of mammalian gene trees and adjacencies, and observe a significant reduction of the number of syntenic conflicts observed in the resulting ancestral gene adjacencies.

Bioinformatics

Integrated Genome Browser: visual analytics platform for genomics

MotivationGenome browsers that support fast navigation and interactive visual analytics can help scientists achieve deeper insight into large-scale genomic data sets more quickly, thus accelerating the discovery process. Toward this end, we developed Integrated Genome Browser (IGB), a highly configurable, interactive and fast open source desktop genome browser.\n\nResultsHere we describe multiple updates to IGB, including all-new capability to display and interact with data from high-throughput sequencing experiments. To demonstrate, we describe example visualizations and analyses of data sets from RNA-Seq, ChIP-Seq, and bisulfite sequencing experiments. Understanding results from genome-scale experiments requires viewing the data in the context of reference genome annotations and other related data sets. To facilitate this, we enhanced IGBs ability to consume data from diverse sources, including Galaxy, Distributed Annotation, and IGB-specific Quickload servers. To support future visualization needs as new genome-scale assays enter wide use, we transformed the IGB codebase into a modular, extensible platform for developers to create and deploy all-new visualizations of genomic data.\n\nAvailabilityIGB is open source and is freely available from http://bioviz.org/igb.\n\nContactaloraine@uncc.edu

Bioinformatics

pcaReduce: Hierarchical Clustering of Single Cell Transcriptional Profiles

MotivationAdvances in single cell genomics provides a way of routinely generating transcriptomics data at the single cell level. A frequent requirement of single cell expression experiments is the identification of novel patterns of heterogeneity across single cells that might explain complex cellular states or tissue composition. To date, classical statistical analysis tools have being routinely applied to single cell data, but there is considerable scope for the development of novel statistical approaches that are better adapted to the challenges of inferring cellular hierarchies.\n\nResultsHere, we present a novel integration of principal components analysis and hierarchical clustering to create a framework for characterising cell state identity. Our methodology uses agglomerative clustering to generate a cell state hierarchy where each cluster branch is associated with a principal component of variation that can be used to differentiate two cellular states. We demonstrate that using real single cell datasets this approach allows for consistent clustering of single cell transcriptional profiles across multiple scales of interpretation.\n\nAvailabilityR implementation of pcaReduce algorithm is available from https://github.com/JustinaZ/pcaReduce

Bioinformatics

Using Cell line and Patient samples to improve Drug Response Prediction

BackgroundRecent advances in high-throughput technologies have facilitated the profiling of large panels of cancer cell lines with responses measured for thousands of drugs. The computational challenge is now to realize the potential of these data in predicting patients responses to these drugs in the clinic.\n\nMethodsWe address this issue by examining the spectrum of prediction models of patient response: models predicting directly from cell lines, those predicting directly from patients, and those trained on cell lines and patients at the same time. We tested 21 classification models on four drugs, that are bortezomib, erlotinib, docetaxel and epirubicin, for which clinical trial data were available.\n\nResultsOur integrative models consistently outperform cell line-based predictors, indicating that there are limitations to the predictive potential of in vitro data alone. Furthermore, these integrative models achieve better predictive accuracy and require substantially fewer patients than would be the case if only patient data were available.\n\nConclusionsThe integration of in vitro and ex vivo genomic data results in more accurate predictors using only a fraction of the patient information, which can help optimize the development of personalized predictors of therapy response. Altogether our results support the relevance of preclinical data for therapy prediction in clinical trials, enabling more efficient and cost-effective trial design.

Bioinformatics

An alternative class of targets for microRNAs containing CG dinucleotide

BackgroundMicroRNAs are endogenous [~]23nt RNAs which regulate mRNA targets mainly through perfect pairing with their seed region (positions 2-7). Several instances of bulge UTR sequence can also be recognized by miRNA as their target. But such non-Watson-Crick base pairings are incompletely understood.\n\nResultsWe found a group of miRNAs which had very few conservative targets while potentially having a subclass of bulge message RNA targets. Compared with the canonical target, these bulge targets had a lower negative correlation with the miRNA expression, and either were downregulated in the miRNA overexpression experiment or upregulated in the miRNA knock-down experiment.\n\nConclusionsWe proved that the bulge target exists widely in certain groups of miRNAs and such non-canonical targets can be recoginized by miRNA. Incorporating these bulge targets, combined with evolutionary conservation, will reduce the false-positive rate of microRNA computational target prediction.

Bioinformatics

IDENTIFICATION OF GENOMIC REGIONS CARRYING A CAUSAL MUTATION IN UNORDERED GENOMES

Whole genome sequencing using high-throughput sequencing (HTS) technologies offers powerful opportunities to study genetic variation. Mapping the mutations responsible for different phenotypes is generally an involved and time-consuming process so researchers have developed user-friendly tools for mapping-by-sequencing, yet they are not applicable to organisms with non-sequenced genomes. We introduce SDM (SNP Distribution Method), a reference independent method for rapid discovery of mutagen-induced mutations in typical forward genetic screens. SDM aims to order a disordered collection of HTS reads or contigs such that the fragment carrying the causative mutation can be identified. SDM uses typical distributions of homozygous SNPs that are linked to a phenotype-altering SNP in a non-recombinant region as a model to order the fragments. To implement and test SDM, we created model genomes with an idealised SNP density based on Arabidopsis thaliana chromosome 1 and analysed fragments with size distribution similar to reads or contigs assembled from HTS sequencing experiments. SDM groups the contigs by their normalised SNP density and arranges them to maximise the fit to the expected SNP distribution. We tested the procedure in existing datasets by examining SNP distributions in recent out-cross and back-cross experiments in Arabidopsis thaliana backgrounds. In all the examples we analysed, homozygous SNPs were normally distributed around the causal mutation. We used the real SNP densities obtained from these experiments to prove the efficiency and accuracy of SDM. The algorithm was able to successfully identify small sized (10-100 kb) genomic regions containing the causative mutation.

Bioinformatics

Bayesian Gaussian Process Latent Variable Models for pseudotime inference in single-cell RNA-seq data

Single-cell genomics has revolutionised modern biology while requiring the development of advanced computational and statistical methods. Advances have been made in uncovering gene expression heterogeneity, discovering new cell types and novel identification of genes and transcription factors involved in cellular processes. One such approach to the analysis is to construct pseudotime orderings of cells as they progress through a particular biological process, such as cell-cycle or differentiation. These methods assign a score - known as the pseudotime - to each cell as a surrogate measure of progression. However, all published methods to date are purely algorithmic and lack any way to give uncertainty to the pseudotime assigned to a cell. Here we present a method that combines Gaussian Process Latent Variable Models (GP-LVM) with a recently published electroGP prior to perform Bayesian inference on the pseudotimes. We go on to show that the posterior variability in these pseudotimes leads to nontrivial uncertainty in the pseudo-temporal ordering of the cells and that pseudotimes should not be thought of as point estimates.

Bioinformatics

Improved metagenome assemblies and taxonomic binning using long-read circular consensus sequence data

DNA assembly is a core methodological step in metagenomic pipelines used to study the structure and function within microbial communities. Here we investigate the utility of Pacific Biosciences long and high accuracy circular consensus sequencing (CCS) reads for metagenomics projects. We compared the application and performance of both PacBio CCS and Illumina HiSeq data with assembly and taxonomic binning algorithms using metagenomic samples representing a complex microbial community. Eight SMRT cells produced approximately 94 Mb of CCS reads from a biogas reactor microbiome sample, which averaged 1319 nt in length and 99.7 % accuracy. CCS data assembly generated a comparative number of large contigs greater than 1 kb, to those assembled from a [~]190x larger HiSeq dataset ([~]18 Gb) produced from the same sample (i.e approximately 62 % of total contigs). Hybrid assemblies using PacBio CCS and HiSeq contigs produced improvements in assembly statistics, including an increase in the average contig length and number of large contigs. The incorporation of CCS data produced significant enhancements in taxonomic binning and genome reconstruction of two dominant phylotypes, which assembled and binned poorly using HiSeq data alone. Collectively these results illustrate the value of PacBio CCS reads in certain metagenomics applications.

Bioinformatics

Construction of the third generation Zea mays haplotype map

BackgroundCharacterization of genetic variations in maize has been challenging, mainly due to deterioration of collinearity between individual genomes in the species. An international consortium of maize research groups combined resources to develop the maize haplotype version 3 (HapMap 3), built from whole genome sequencing data from 1,218 maize lines, covering pre-domestication and domesticated Zea mays varieties across the world.\n\nResultsA new computational pipeline was set up to process over 12 trillion bp of sequencing data, and a set of population genetics filters were applied to identify over 83 million variant sites.\n\nConclusionsWe identified polymorphisms in regions where collinearity is largely preserved in the maize species. However, the fact that the B73 genome used as the reference only represents a fraction of all haplotypes is still an important limiting factor.

Bioinformatics

A pathway-centric view of spatial proximity in the 3D nucleome across cell lines

Spatial organization of the genome is critical for condition-specific gene expression. Previous studies have shown that functionally related genes tend to be spatially proximal. However, these studies have not been extended to multiple human cell types, and the extent to which context-specific spatial proximity of a pathway is related to its context-specific activity is not known. We report the first pathway-centric analyses of spatial proximity in six human cell lines. We find that spatial proximity of genes in a pathway tends to be context-specific, in a manner consistent with the pathways context-specific expression and function; housekeeping genes are ubiquitously proximal to each other, and cancer-related pathways such as p53 signaling are uniquely proximal in hESC. Intriguingly, we find a correlation between the spatial proximity of genes and interactions of their protein products, even after accounting for the propensity of co-pathway proteins to interact. Related pathways are also often spatially proximal to one another, and housekeeping genes tend to be proximal to several other pathways suggesting their coordinating role. Further, the spatially proximal genes in a pathway tend to be the drivers of the pathway activity and are enriched for transcription, splicing and transport functions. Overall, our analyses reveal a pathway-centric organization of the 3D nucleome whereby functionally related and interacting genes, particularly the initial drivers of pathway activity, but also genes across multiple related pathways, are in spatial proximity in a context-specific way. Our results provide further insights into the role of differential spatial organization in cell type-specific pathway activity.

Bioinformatics

Laplacian eigenmaps and principal curves for high resolution pseudotemporal ordering of single-cell RNA-seq profiles

Advances in RNA-seq technologies provide unprecedented insight into the variability and heterogeneity of gene expression at the single-cell level. However, such data offers only a snapshot of the transcriptome, whereas it is often the progression of cells through dynamic biological processes that is of interest. As a result, one outstanding challenge is to infer such progressions by ordering gene expression from single cell data alone, known as the cell ordering problem. Here, we introduce a new method that constructs a low-dimensional non-linear embedding of the data using laplacian eigenmaps before assigning each cell a pseudotime using principal curves. We characterise why on a theoretical level our method is more robust to the high levels of noise typical of single-cell RNA-seq data before demonstrating its utility on two existing datasets of differentiating cells.

Bioinformatics